EyeCRO, Calvert Labs Partner to Perform Preclinical Studies of Ophthalmic Drugs

EyeCRO, an Oklahoma City, Okla.-based research company focusing on ophthalmic disease, has partnered with Calvert Labs, a Cary, N.C.-based medical device and pharmaceuticals discovery and development company, to perform preclinical studies of treatments for ophthalmic diseases, according to an Outsourcing-pharma.com report.

Advertisement
Carrie Pallardy

The partnership was formed because the two companies perceived an increase in market demand for preclinical ophthalmology studies.

More Articles on Ophthalmology:
Dr. Paul Winslow Joins New Vision Retina Center
Piedmont Eye Center Chooses SRS EHR
UK Researcher Discovers Undetected Layer in the Cornea

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.